Teladoc Health, Inc. (NYSE:TDOC) Stock Holdings Boosted by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 1.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,925,167 shares of the health services provider's stock after acquiring an additional 56,864 shares during the period. Geode Capital Management LLC owned about 2.28% of Teladoc Health worth $36,042,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of TDOC. Signaturefd LLC lifted its holdings in Teladoc Health by 148.7% in the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock valued at $28,000 after purchasing an additional 1,715 shares in the last quarter. International Assets Investment Management LLC purchased a new position in shares of Teladoc Health during the second quarter valued at approximately $29,000. Blue Trust Inc. lifted its stake in shares of Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock valued at $40,000 after buying an additional 1,854 shares during the period. Doheny Asset Management CA acquired a new stake in Teladoc Health during the second quarter worth approximately $46,000. Finally, Benjamin F. Edwards & Company Inc. grew its stake in Teladoc Health by 209.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider's stock worth $49,000 after acquiring an additional 3,396 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Buying and Selling

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the business's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares of the company's stock, valued at $34,477.70. The trade was a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.95% of the stock is owned by company insiders.

Teladoc Health Stock Up 2.9 %

Teladoc Health stock traded up $0.27 during midday trading on Thursday, hitting $9.53. The stock had a trading volume of 3,468,742 shares, compared to its average volume of 5,499,265. The business has a fifty day moving average price of $9.85 and a 200 day moving average price of $9.08. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $22.54. The stock has a market cap of $1.64 billion, a P/E ratio of -1.65 and a beta of 0.97. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million during the quarter, compared to analyst estimates of $630.50 million. Research analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Analyst Ratings Changes

TDOC has been the topic of several analyst reports. Jefferies Financial Group raised their price objective on Teladoc Health from $8.00 to $10.00 and gave the stock a "hold" rating in a report on Tuesday, September 17th. TD Cowen decreased their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, October 31st. Barclays upped their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an "overweight" rating in a research note on Thursday, October 31st. Evercore ISI raised their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a "hold" rating in a research report on Friday, November 1st. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and an average price target of $12.24.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.